Unknown

Dataset Information

0

Elimination of Dirofilaria immitis Infection in Dogs, Linosa Island, Italy, 2020-2022.


ABSTRACT: On Linosa Island, Italy, Dirofilaria immitis infection has been hyperendemic in dogs and seroprevalent among islanders. In 2020, we implemented a heartworm disease elimination program on Linosa Island. Of 54 dogs tested for D. immitis antigen and microfilariae, 28 had positive results and received treatment with oral doxycycline twice daily for 4 weeks plus topical imidacloprid/moxidectin monthly for 12 months. The 26 dogs with negative results received monthly topical imidacloprid/moxidectin as preventive. During month 1, the number of microfilaremic dogs was reduced by 76.5%. From month 2 on, all animals were microfilariae negative, and during months 3 to 9, the number of antigen-positive dogs decreased progressively. Treatment of positive dogs coupled with chemoprophylaxis for noninfected dogs was effective, protecting them from new infections. The elimination program reduced the risk for human infection, representing a One Health paradigm. Monitoring and chemoprophylaxis are advocated to maintain the status of heartworm disease-free area.

SUBMITTER: Brianti E 

PROVIDER: S-EPMC10370836 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Elimination of Dirofilaria immitis Infection in Dogs, Linosa Island, Italy, 2020-2022.

Brianti Emanuele E   Napoli Ettore E   De Benedetto Giovanni G   Venco Luigi L   Mendoza-Roldan Jairo Alfonso JA   Basile Angelo A   Bezerra-Santos Marcos Antônio MA   Drake Jason J   Schaper Roland R   Otranto Domenico D  

Emerging infectious diseases 20230801 8


On Linosa Island, Italy, Dirofilaria immitis infection has been hyperendemic in dogs and seroprevalent among islanders. In 2020, we implemented a heartworm disease elimination program on Linosa Island. Of 54 dogs tested for D. immitis antigen and microfilariae, 28 had positive results and received treatment with oral doxycycline twice daily for 4 weeks plus topical imidacloprid/moxidectin monthly for 12 months. The 26 dogs with negative results received monthly topical imidacloprid/moxidectin as  ...[more]

Similar Datasets

| S-EPMC9696258 | biostudies-literature
| S-EPMC5055658 | biostudies-literature
| S-EPMC10139826 | biostudies-literature
| S-EPMC7507288 | biostudies-literature
| S-EPMC7020351 | biostudies-literature
| S-EPMC5688474 | biostudies-literature
| S-EPMC3557977 | biostudies-literature
| S-EPMC7824140 | biostudies-literature
| S-EPMC9559157 | biostudies-literature
| S-EPMC7161282 | biostudies-literature